CHARITY COMMISSION Lung Cancer Nursing UK ANNUAL REPORT AND ACCOUNTS FINANCIAL YEAR ENDING JANUARY 2025 Charitable Incorporated Organisation number: 1160011 LUNG CANCER NURSING UK I FIFTEEN Rosehill. Montgomery Way, Rosehill Estate CARLISLE, CAI 2RW
TRUSTE. REPORT Forthew4reDded 31January2025 About LCNUK Lung Cancer Nursing UK was established in 1998 to support the advancement of health by providing nurses who specialise in the treatment of patients with lung cancer or mesothelioma with support, education and the opportunityto communicate and network with peers; and to provide a national voice on clinical and strategic issues for specialist lung cancer nurses. The organisation became a charitable incorporated organisation ICIOI in 2015. Membership is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer and or mesothelioma within the NHS environment. A separate associate membership scheme is available for Lung Cancer Navigators/Care Coordinators and a550ciate membership is also open to those who do not meet the criteria for full membership. The experience and clinical background of the members working environments are very diverse, including, palliative care. oncology (cancer centres or units) respirdtory medicine. community and others. this affords the organisation a wealth of knowledge into which member5 can access. The activities of the CIO fall into four distinct categories, these are as follow5: Clinical Improving the care lung cancer patients receive. Disseminating best practice and sharing information and knowledge Developmental Keeping members up-to-date with the latest lung cancer news through our e-bulletins Hi8hli8hting new developments in the UK. Encouraging regional participation within LCNUK Education Providing a forum to disseminate new developments. skills, treatments and practice through educational programmes, annual conference, resources and publications Sharing clinical updates and best practi with members Supporting and fostering audit and research in lung cancer and within the role of the LCNS Professional Providing sUPPOrt and netrNorkin8, infrastructure and opportunities. CampaiBning for and supporting the role of the lung cancer nurse specialist Providing a voice on clinica5 and strategic issues. Highlighting the specialist role of nurses in caring for people with lung cancer and mesothelioma Representing lun8 cancer nurse specialists on national and international bodies and organisations LUNG CANCER NURSING UK IA ¢harltsble Incorptsvdtsd organtsatlon iao-tharlty Number 116(¥MII Page I
TBUSIEES, REPORT FOrth@end 3lJ4nuary2025 2025 Business Priorities The Trustees present their annual report together with the financial statements of the charity for the year I February 2024 to 31 January 2025. The Trustees confirm thatthe Annual Report and Financial Statements of the charity comply with the current statutory requirements, the requirements of the charitys governing document and the provisions of the Statement of Recommended Practice ISORPI applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021 (effective l January 20191. The Trustees have complied with the duty in part I section 4 of the Charities Att 2011 to have due regard to public benefit guidance published by the Charity Commission. A detailed report of the activities undertaken and achievements by the Charity to further its charitable purposes for the publlc benefit is given below In 2025, LCNUK priorities were unchanged: Professional To act as advocates for patients with lung cancer on national professional bodies such as NICEIBTOG. To represent the lung cancer nurse specialist on professional bodies and committees and provide a voice on strategic i55ues at a regional and national level. To promote the lung cancer nurse specialist role and its benefits on an intemational platform. To share best practice in lung cancer and mesothelioma care. Developmental To continue production and circulation of a monthly e-bulletin to share best prartice and highlight lung cancer and relevant nursing news and events. To maintain the LCNUK website creatin& sharing and signposting to relevant news and events. Education and Clinical Annual Conference June 2024-To provide ongoing professional education to lung cancer nurse specialists through its annual conference. To provide regular educational programmes of activity including webinars and podcasts. Research To support ongoing research programmes with academic institutions and provide small research grants to support lung cancer nurse specialists taking their first steps in research and those seeking advanced care practitioner stalus. LUNG CANCER NURSING UK IAcharliable incorporot¢d oryanlsètlon ICIO-(tharity Number 11600111 Page 2
TRUSTEES'REPORT Forthesearended aijanuary 2025 2024 Impact report The continued pressure of work experienced by lung cancer nurse specialists has not abated during this period. Significant challenges remain due to high caseloads, staffing shortage5 and increasingly complex patient cases Wlth multiple morbidity and complex treatment regimens. National guidelines recommend Caseload of no more than 80 new patients per year but many nurses are exceeding this limit carrying from between 100 and 200 patients and, as treatments improve and patients live longer there are increasing ongoing needs of lung cancer survivors that also have to be met. The struggling workforce impacts on what LCNUK, as a professional organisation, can do to support the workforce. Increasingly, we have had to resort to the development of short fomi digital media to support educatlon and professional development as fewer nurses are able to tske time away from the coal face for meetings and courses. Efforts have been put in place to support the workforce through the appointment of Navigator5/Cancer Care Coordinators LCNUK has recognised the growing importance of the role of the Navigator and has opened up associate members for navigators working in lung cancer with projects ongoing to share best prattice and optimise the relationship between lung cancer nurse specialist and navigator. During 2024 membership of all types of members increased slightly to 293. 'Any mernber who paid for a membership in 2020, h35 had their membership end date extended to 2022 Professional Influencin8 and contribution to natir)nal polky LCNUK works alongside many organisations across the UK to inforn) lung cancer policy, promote best practice and act as the patients advocate for people with lung cancer. In 2024, we contributed to collaborate with national bodies including NICE, BTOG. UKLCC. Roy Castle Lung Canr Foundation and other lung cancer related organisations to support the development of national policy and guidelines. The organisation has continued to support Lung Cancer Europe Activities which have had number of initiatives taking place. In 2024 we implemented an ambitious programme of work to explore how to assess patient complexity and its impact on the staffing requirements for lung cancer nurse specialists. A questionnaire was developed and piloted wlth members of the committee before being taken out to the membership through our annual project workshop. The outputs of the work will be shared with LCNUK members in June 2025 and through abstracts submitted to BTOG and the World Conference on Lung Cancer in 2025. Navigator/supFK)rter roles as described in the N*ional Optimal Lung Cancer Pathway silPPOrt healthcare protessianals by taknng on administrative and cwrdin3tor rolesto 5UPPOrt Lun8 Canr Nurse Specialists and deliver a more patient friendly and patient centred experience LUNGCANCER NURSING UK IAthafftable IncowpoTrted or8anlsatlon ICIO-Charfty Number11600111 Page 3
TRUSTEES, REPORT Fortheye4rended31Jintsary 2025 Representation British Thoracic Oncology Group Clinical Expert Group ILung Cancer) Global Lung Cancer Coalition International Thoracic Oncology Nurses Forum Lung Cancer Europe Mesothelioma UK National Lung Cancer Audit National Institute for Health and Care Excellence Roy Castle Lung Cancer Coalition Scottish Medicines Con50rtium Scottish Lung Cancer Nurses Forum UK Lung Cancer Coalition Welsh Lun8 Cancer Nurses Forum The group has also collaborated and supported gene specific patient groups and Ruth Strau55 Foundation Developmental Communlcating with our members LCNUK has continued to deliver short fomi Succinct Communications with members providin8 bite-size news and informatlon that can be absorbed in the short window of tirne available to our members. To facilitate this, we continue to use social media to push out key mes53ges, re8ularly update the content on our website with direct links from the home page to key important lung cancer 3nd nursing news. We also prepare and deliver a monthly members newsletter featuring bite-size news and signpostlng members to educational and professlonal development information as well as updates on key lung cancer news and links to other charity and not-for-profit news. Professional In 2024, LCNUK launched a new £20,000 fund initiative to support leadership training, Member5 fulfilling specific criteria have the opportunity to apply for grant funding to support NHS approved leadership courses. Two applications have been received and approved for funding. Those awarded the grant are required to support LCNUK activities upon completion to share their learning and agree to help mentor future applicants. LUNG CANCER NURSING UK IA¢haritable Inc¢rporated or8ani5aliDD ICIO-Charlty Number 116LMIIII Page 4
TRUThES' REPORT Forthowr•nd 31JanuBry2025 Education and clinical In 2024 we hosted our annual conference at The Hilton Hotel Glasgow. The conference attracted 305 attendees of which 149 were members of LCNUK. 97% ofthosewho completed the evaluation reported that the Conferen was relevant to their educational needs with similar numbers reporting that the information was well presented by knowledgeable and appropriate speakers. This was the first time the conference exceeded delegates since COVID-19 and shows promise for the future role of our annual conference. In taking the learning from the conference it was agreed that future conferences may offer 3 trial of multi-stream educational content to allow those attending to personalise their conference experience based on their own learning needs. The organisation hosted five webinars in 2024 which members could attend live or watch on-demand at their leisure. These included.. Lung cancer in the LGBTQIA community May 2024 Peter Barton Management of Mesothelioma June 2024 Leah Taylor Understandlng and managing frailty in lung cancer July 2024 Fabio Gomes Common mental health presentations in lung cancer September Asanga Fernando & Jo 2024 Ashcroft Smoking cessation- how you can support your patients to qult Nov 2024 Professor Sanjay Agrawal In 2024 we also introduced 3 new learning medium by offering members exclusive access to a new podcast platform. Two podcasts were launched wtth more planned in 2025. In 2024 we also. in collaboration with Mesothelioma UK, updated existing and produced new resources on the diagnosis and management of mesothelioma. A dedicated learning module was developed that users could undertake after studying the resources to test knowledge and receive a certificate of completion for professional portfolios and CPD. Research LCNUK has a small workgroup of active members interested in research {known as RIG- Research Interest Group) led by Suriya Kirkpatrick. The group contribute to ongoing lung cancer research projects and promote access to clinical trials. Regretfully, there were no suitable applications for small grants in 2024. LCNUK recognise this is a symptom of the pressure on the lung cancer workforce with little to no time available for research work. 29 abstracts were submitted to the LCNUK annual conference {v5 21 in 20231. Three applications were received for our annual award programme. LUNG CANCER NURSING UK IA charltable IncoTporatsd orDni5alipn ICIO-Charlty mber 11600111 Page5
TRUSTFES. REPORT Forthayearended 31Jènuary2025 Another sub-group of members, the thoracic surgical group. continued working on 3 project, 'Is surglcal follow-up equiknbleforollpat1ent. The results of work will be submitted as an abstract for presentation at a national conference. Plans For Future Periods In 2025, LCNUK will be finalising its plans and implementing a programme of work to develop a patient complexity tool. We will be seeking ta influence the national agenda to ensure that patients have timely and appropriate access to lung cancer nurse specialists to advocate for patients in the lung cancer journey. We will continue to act as patient representatives and advocates at a national policy level. We will continue to collaborate with partner organisations to support seNice delivery, timely diagnosis and appropriate management for people with lung cancer. We will be collaborating with lung cancer groups in Australia to promote the value of the lung cancer nurse specialist role. We will promote best pr2Ctice through the sharing of clinical knowledge and ski115 at our 3nnual flagship two-day conference in June 2025. Alongside our conference we will continue to deliver digital learning programmes including webinars. podcasts and online learning modules to support professional development. We will work to develop a framework for best practice for navigators/cancer care coordinators and highlight the benefits of the role in supporting lung cancer nurse specialists to deliver effective and timely care for people with lung cancer. We will continue to promote member communications. the sharing and di55emination of relevant lun8 cancer news and information. In June 2025 we will undertake a strategy revlewto explore howwe can best support LCNUK members and influence best practice in lun8 cancer care and support in the short medium and longer term. Structure, Governance & Management Constitution The charity is a registered charitable incorporated organisation, charity number 1160011. Formal membership is open to any lung cancer nurse specialist who spends More than 50Yo of their working week or clinical activities in caring for patlents with lung cancer or mesothelioma in the UK NHS. In addition. associate membership is open to healthcare professionals, navigator51cancer care coordinators in a lung cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such membership is subject to approval by the LCNUK Committee. Method of appointment and election of trustees The management of the charity is the responsibility of the trustees who are elected and co-opted under the terms of the constitution. During this period the LCNUK was managed by ten trustees, led by Diana Borthwick who took up the role as chair from 5 January 2024. The trustees, orany member of LCNUK can LUNG CANCER NURSING UK IA charitsble IOrPOrated organlsatlon ICIO-Charrty Numbr116rxii Page 6
TrUSTEES' REPORT ForthewJrended 31January2025 recommend a trustee for appointment. One third of the trustees retire each year and may be re-appointed. Applicants are asked to provide a CV and covering statement. A shortlist is drawn up and interviewed by a panel appointed by the Board of Trustees. Three co-opted trustees were formally appointed at the AGM in June 2024 Nicola Handley, Dominic Smith and Catherine Haywood. Lorraine Creech. Isobel Lovett and John White were reelerted in June 2024, though Isobel Lovett later resigned on 3 July 2024. Despite extensive efforts the trustees were unable to get hold of Rory Undenmood. A final letter was sent and he was removed from the board in February 2024. Alison Leary resigned in November 2024. Policies adopted for the induction and training of trustees A trustee recruitment and induction pack is available to support new trustees in learning about the organisation. its role, governance and responsibilities of trustees. The trustee terms of reference and trustee manual was reviewed and updated in 2024. A trustee skills audit was undertaken in 2024. LCNUK is also a member of the National Council for Voluntary Organisations to take advantsge of governance training opportunities. Organisation structure and decision making The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee attends trustee meetin8S to ensure continuity and good communications. During 2024 the committee was comprised of 12 elected members of LCNUK and three co-opted members, Suriya Kirkpatrick. Ali50n Edwards and Matthew Kelly. The LCNUK committee formulates recommendations on the aims, strategies and activities of the charity for approval by the trustees. An agency. Red Hot Irons Limited IRHII. is contracted to run the day-to-day business administration and operations of the organisation. Pay Policy for key management There are no paid staff. all work undertaken bythe committee and trustees is done so voluntarily. The support agency is contracted to run the operational day-to-day activities and business administration. Application and adherence to the Charity Governance Code LCNUK recognise good governance is essential to our effectiveness, reputation 3nd credibility. The Board of Trustees regularly review activities. policies and pro55eS to ensure the charity is delivering against its mission and charitable objectives. We have robust measures in place to ensure effective and clear ovÈNiew of financial controls. The board undertakes a regular review (every two years) of its effectiveness. assessing competencies, skills gaps and training needs through a process of external audit and facilitated discussion. In 2024, LCNUK adopted a new policy on disciplinary procedures and updated its policies on Membership. Privacy, Safeguarding and Well-bein& Antiharassment and bullying. The investment, reserves and risk management policies were also reviewed as part of the routine governance of the organisation. We operate a robust conflicts of interest policy. and all Trustees and Committee members complete declarations of interest each year. Conflict of interests form a standing item on all committee/board agend3s. The Board aims to continuously improve its governance processe5 and is currently working through the new Charit Gove.rn3nce Code to ensure its governance structures adhere to the principles of the code and recommended prartice. Risk management The Trustees analyse and undertake a review of the risks the Charity is exposed to as part of an annual business planning process and in accordance with Charity Commission guidance (CC26), scoring the risks LUNG CANCER NiIRSING UK IAch7ritsble incorporated organlsatlon IC10-Crlty Number 11600111 Page 7
TRUSTEES. REPORT Forthe yearded 31Januiry2025 accordin8 to likelihood and impact. The systems and actions established to mitigate those risks are also reviewed by Trustees at each Board meeting and updated and adjusted accordingly. with the net risk in each area agreed. High risks closely monitored by the Trustees are: High level of dependency on too few income streams puts LCNUK at risk of sudden and/or long-term loss of funding- efforts continue to diversify income streams to include more Trusts and Foundation as well as funding from non-pharmaceutical companies. Potential for a sudden drop in income and the need to dip into accumulated reseNes The risk that LCNUK could be perceived as being unduly influenced by sponsors/pharmaceutical industry. LCNUK has adopted a strinEent endorsement policy and ensures where possible that there is a balance of sponsors from across the industry spectrum with no one sponsor having significant influence or control. Sponsors are not permitted to have any form of editorial control or influence overthe contentand developmentof new LCNUK branded materials In 2024, LCNUK opened two new bank accounts to mitigate financial risk and maximise Financial SeNice5 Compensation if required. Further work in this area 15 planned to ensure the safety of funds and maximise safe return5. Volunteers The Society is heavily reli3nt on the time, expertise and energy of rts committee and other members. Much of the work of the charity is conducted virtually via email and teleconference and is undertaken on a voluntary basis. LUNG CANCER NURSING UK IA ¢h8rltable In¢oryttsrated or8anlsatksn ICIO-Charity Number 11600111 Page 8
TrU5TEts'AEPORT r thewarended 31J4nu4ry2025 Trustees, executive committee & senior management Trustees Accountants David Baldwin George Bate Ir&elected 21 June 20241 Diana Borthwick IChair- appointed January 5 20241 Lorraine Creech ITelected 21 June 20241 Nicola Handley lelected 21 June 20241 Catherine Haywood (elected 21 June 20241 Allson Leary Iresigned l November 20241 Isobel Lovett (resigned 3 July 20241 Dominit Smith lelected 21 June 20241 Rory Underwood (removed 29 February 20241 John White (re-elected 21 June 20241 Dodd & Co Chartered Accountants FIFTEEN Rosehill Montgomery Way Rosehill Estate Carlisle CAI 2RW Bankers Unlty Trust bank plc Nine Brindley place Bimiingham 812HB LCNUK Committee Vlctorta Anderson (resigned Nov 20241 Peter Barton Karen Clayton ICHAIRI Pamela Dalrymple Marie Eaton Isabbatical from June 20241 Annabel Grinberg5 lelerted Nov 20241 Emma Halkyard Ico-optedl Sarah Ivey (resigned Nov 20241 Lavinia Magee Iresigned Nov 20241 Julia McAdam Karen Mccrae lelerted Nov 20241 Jennrfer Ross Ire-elected Nov 20241 Paula Shepherd Charlotte Smith Bing Smith Jane Weir (elected Nov 20241 Nationwide Building Society Nationwide House Pipers Wav Swndon SN38 INW The Charity Bank Limited, Fosse House. 182 High Street. Tonbridge. TN9 IBE Teachers Building Society.. Allenview House, Hanham Road, Wimborne, Dorset, BH21 IAG Co-opted LCNUK Committee members Suriya Kirkpatrick (Research Interest Group Lead) Matthew Kelly INI representative) Allson Edwards (Welsh representativel resigned Jan 2025 Registered office clo Dodd & Co FIFTEEN Rosehill Molltgornery Wav Rosehill Estate CARLISLE CAI 2RW Charity Registeted Number 116(K>ll WNG fANCER NURSING UK IAcharitsble in¢orporatsd or£an15atlon ICIO-Charhy Number 11600111 Page 9
TREISTEES. REPORr Forthéye4rended31J•nuary 2025 Financial Review Principal Funding The principal funding sources for the Charity in 2024 as in previous years were: Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate Sponsorship) Income from sponsorship of charitsble activities by pharmaceutical companies andlor solicitors Membership fees The total funding secured in 2024. £232.804 an increase of £68,582, this was largely due to the charity attracting corporate sponsorship from two sponsors. We were also able to attract a grant of £5,000 to 5UPPOrt our leadership programme. We were also able to secure additional investment interest through spreading income across different bank accounts with increased interest rates which allowed us to attract £6,808 vs £1,086 in the prior year. Membership fees were similar to 2024 but we attracted additional paying delegates to the conference resulting in a conference registration income of £30,793 vs £22,356 in the prior year. Principal Expenditure Total expenditure in 2024 was £157,611. This represents an increase in expenditure of £1,672, an increase of less than 2% on the prioryear. We feel confidentthat we have managed to contain expenditure in spite of external influences and rising interest rates. The largest item in support costs was secretsriat, membership and administration costs, which includes fees paid to Red Hot Irons. Red Hot Irons is contracted to run the day-to-day operations of the charity, including book-keeping, governance support, maintenance and upkeep of ourwebsite, membership management and communications. committee management, events, IT, webinars. analytics and database. Reserves Policv LCNUK has no regularguaranteed sources of income and the long-term funding of the charity is uncertain. The charity however does have fixed operating costs in terms of the activities required to maintain its presence and further its charitable objectives. The charivs work is planned one year in advance with financial commitments made up to two years in advance on some programmes such as the annual conference. The Trustees have therefore decided that to see programmes through to completion in the event of serious reduction in fundin& an optimal reserve equivalent to twelve months fixed operating costs plus the annual cost of the conference should be held. This level of reserve also supports the charity in working to a long-term strategy without the need to make short term adjustments forced on it by temporary deficits in funding. Moreover. it allows the charity to take advantage of opportunities that may present and require a relatively small or moderate investment upfront. Minimum and maximum levels of reserves have been agreed a5 6 months costs and 18 months costs respectively. TheTrustees will be guided only to tske drastic action if they see the charity falling below its minimum level of reserves and to only make slgnlficant long- term investments from reserves if the Charity is above its ideal level of reserves. The optimum level of reserve based on the 2025 budget amounts to £266k with a minimum of £133k. The level of free unrestricted reserves held by the Society at the end of the accounting period {Jan 20251 was £403.768, which meets the optimum level of maximum reserves. LUNG CANCER NURSING UK (Acharhable inorpDrated or£an157tlan ICIO-Ch8rity mber 11600111 Page 10
TAUSTEES'REPORT For there 31J4nvJry2a25 The Board undertakes an annual review of the reserves policy to ensure it reflects current activities of the charity and amounts held in reseNe are sufficient meet the financial and charitable obli8ations should funding significantly diminish for any reason. Going concern After making appropriate enquiries. the Trustees have a reasonable expectation that the charity ha5 adequate resources to continue in operational existence for the foreseeable future. For this reason, they contlnue to adopt the going concern basis in preparing the financial statements. Further details regardin8 the adoption of the going concern basis can be found in the accounting policies. Financial Review Conclusion The Society ended the year with an operating surplus of £75,193 for the accounting period. The charity continues to hold healthy reserves. However, sponsorship and funding remain a significant thallenge and operating costs continue to rise particularly around venue hire charges and insurance costs. The Trustees recognise that the funding situation remains challenging and will continue to be innovative in our approach to fundraisin& cost savings and ensuring value for money. We will also look to achieve additional funding from grant making bodies. Statement of Trustees, responsibilities The Trustees are responsible for preparing the Trustees, report and the financial Statements in accordance with applicable law and United Kingdom Accounting Standards Iunited Kingdom Generally Accepted Accountin8 Practice). Charity law requires the Trustees to prepare financial statements for each financial year. Under charity law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustee5 are required to- select suitable accounting policies and then apply them consistently. observe the method5 and principles of the Charities SORP (FRS 102}; make judgments and accounting estimates that are reasonable and prudent; state whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to any material departures disclosed and explained in the financial statements: prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. LUNG CANCER NURSING UK (A charltable incorporatsd OT8anlsatlan ICIO-Chorfrty Number 11600111 Page 11
TRUSTE. REPOHT FortheyeèrEnd 31Jihutry2025 Disclosure of information to independent examiner Each of the person5 who are Trustees at the time when this Trustees, report is approved has confirmed that: so far as that Trustee is aware. there is no relevant information of which the charity's accountant and independent examinerare unaware, and that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any relevant informatlon and to establish that the charity's accountants are aware of that information. Approved by order of the members ofthe board of Trustees and signed on their behalf by: Diana Borthwick Chair of the Board of Trustees Date: a)061C)2 LUNG C4NCER NURSING UK IA¢harftablÈ IrKorpor3ted or8anivtiw ICIO-Charhy Nurnber 11600111 Page 12
Ind6pendent Examinerfs Report to the Trustaos of Lung Cancer Nursing UK I report on the accounts of the ¢harily for the year ended 31 January 2025, which are Set out on pages 14 to 22. Your attention is to drawn to the fact that the Charity has prepared the financial statements in accordance with Accounting and Reporting by Charities Preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 in preference to the Accounting and Reporting by Chartties.. Statement of RecornTnended Practice issued on 1 April 2005 which is referred to in the extant regulations bul has since been withdrawn. We understand that this has been done in order for the accnunts to provide 8 true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2019. Respective responsibilities of trustees and examiner The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year under section 144{2) of the Chartties Acl 201 I as amended by the Charities Act 2022 {the Act) and that an independent examination is needed. It is my rasponsibility to.. examine the accounts under section 145 of the Act., follow the ProdureS laid down in the General Directions given by the Charity Commission under section 14515) Ibl Of the Act., and stste whether particular matters have come to my attenlion. Ba818 of independent axaminerfs report My examinab'on was carried out in accordan thi the General D1CtionS given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented wth those records. It also inciudes ¢onsideration of any unusual items or disdtssures in the accounts. and seeking explanations from you as trusteès conceming any such matters, The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'lrue and fair view, and the report is limited to those matteTS set out in the statement below. Independent examinevs statement In connection with my examinalian, no matter has come to my attention- {11 which gives me reasonable cause to believe that in any material respect the requirements= to keep accounting records in accordan with section 130 of the Charities Act 2011 as amended by the Charities Act 2022., and to prepare accounts which accord with the accounting records, comply with the accounting requirements of the Act have not been met.. or 12) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA1 2RW nne Thom Inson FCA d & Co Limited Chartered Accountants 12 May 2025 Page 13
Lung Cancer Nursing UK known as LCNUK ststement of Financial Activities for the Year Ended 31 January 2025 Unrestricted Total Funds Totsl Funds Fund$ 2025 2024 Income and endowments from: Donations and legacies Inveslment income Charitable activities Total income 162,845 6,808 63,151 232,804 162,845 6,808 63,151 232,804 123.100 1,086 40,036 164,222 Expendlture on: Charitable activities Total expenditure 157,611 157,611 157,611 157,611 155,939 155,939 Netmovements in funds 75,193 75,193 8.283 Reconciliation of funds Total funds brought forward Totsl fvnds carried forward 328,575 403,768 328,575 403,768 320.292 328,575 The notes on pages 16 to 22 foTm an integral part ofthese financial ststements. Page 14
Lung Cancer Nursing UK trading as LCNUK Balance Sheet as at 31 January 2025 2025 2024 Note Cuffent assets Debtors Cash al bank and in hand 10 58,401 375.181 48,232 338.078 433,582 386,310 Creditors: Amounts falling due within one ar 11 129,8141 157,735) Net current assets 403,768 328,575 Net assets 403,768 328,575 The funds of the charity: Unrestricted fvnds Unrestricted income funds 403,788 328.575 Total charity funds The finanaal statements have been prepared in accordance with the Finanaal Reporting Standard applicable in Ihe UK and Republic of Ireland IFRS 1021. 403,768 328,575 Approved by the Board on 12 May 2025 and signed on its behalf by.. D Borthwick Trustee The notes on pages 16 to 22 fomi an integral part ofthese financial statements. Page 15
Lung Cancer Nur8lng UK known as LCNUK Notes to tha Flnancial Statam8nts for the Year Ended 31 January 2025 Accounting pollcles Statement of complTance The accounts (financial ststements) have been prepared under the historical cost convention wth items recognised at cost or transaction value unless otherwise stated in the relevant note{sl to these accounts. The financial statements have been prepared in accordan with the second edrtion of the Charitses Statement of Recommend1 Practice issued in October 2019. the Finanal Reportrng Standard applicable in the United lQngdom and Republic of Ireland IFRS 102) and the Charities Act 2011 as amended bv the Charibes Act 2022. The accounts Ifinanual statements) have been prepared to give 8 'true and fairf view and have departed from the Chatitses (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair view. This departure has involved following Accounting and Repong by Charities preparing their accounts in accordance with the Financial Reporting Stsndard applicable in the UK and Republic of Ireland (FRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practi effective from 1 April 2005 which has since been withdrawn. Basis of prgparation The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cosl or transaction value unless otheNise stated in the relevant accounting policy notes. Going concom These financial ststements have been prepared on a going concern basis.The trustees assess whether the use of going conc&m is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the Charity to continue as a going concem. The trustees make this assessment in r•spect of a period of one year from the date of approval of the financial sL8tements. Fund accounting policy Unrestrictod Income funds are general funds that are available for use at the trustees, discretion in furtherance ofthe objeclives of the charity. Further details of each fund are disdosed in note 13. Income and endowments Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and the amount L3n be measured suffiaent reliability. Income from Govemment and other grants. whether'capital. grants or'revenue, grants, is recognised when the charity has entitlement to the funds, any performance condiknons attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred. Investrnent income is recognised on a re1vable basis. In¢ome from charitsble actiwtl8s include5 income recognised as eamed {as the related goods or services are provided) under contract. Membership income is regnised on receipt Page 16
Lung Cancer Nurslng UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2025 conlinu8d Expendlture Liabilities are recognised as soon as there is a legal or constrL¢ciive obligation committing the ¢harity to the expenditure. All expenditure is accounted for on an accruals basis and has teen dossified under headings that aggregate all costs related to the category. Expenditure on raising funds are the costs of trading for fundraising puoses. Charitable expenditura compris6s those costs incurred by the charity in the delivery of tts aCtieS and services for its beneficiaries. It includes both costs that can be allocated directly to such actiwiies and ihose costs of an indirect nature necessary to support them. Grants payable are payments made to third parties in the furtheran of the oharitable objectives. Where the charity gives a grant with conditions for its payment being a specific level of service tsr output to be provided, such grants are only recognised in the SOFA On the recipient of the grant has provided the specifiG servtce or output. Grants payable without performance conditions are only recognised in the accounts when a commitment has been made and there are no conditions lo be met relating to the grant which remain in the control of the charity. Provision8 for grants are made when the inlention to make a grant has been communicated to the recipient but there is uncertainty 8bout either the timing of the grant or the amount of gr8nt payable. Support costs Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources. for example, allo¢ating propety costs by floor areas, or per capita, stsff costs by the time spent and other costs by their usage. Irrocoverable VAT Irrecoverable VAT is charged against the category of resour8 expended for which it was incurred. Cash and Cash Equivalènts Cash and cash equivalents comprise cash on hand and call deposits, and other short-temi highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. Donations and1ogaci8s Unrastrlcted Total Funds Totsl Funds Funds 2025 2024 Donatlons and legacies Conference sponsorship Corporate sponsorship 140,845 22,000 162,845 140,845 22,000 162,845 123,100 123,100 Of the donations and legaaes income in 2024 £123.100 related to unrestricted funds. Page 17
Lung Cancer Nurslng UK known as LCNUK Notes to the Financial Statements forth8 Yaar Ended 31 January 2025 . continued Investrnant income Unrostri¢tsd Total Funds Total Fund8 Funds 2025 2024 Interest on cash deposits 6,808 6.808 1,086 Of the investment income in 2024 £1,086 related to unrestricled funds. Charitsble activities Unrestrlcted Total Funds Total Funds Funds 2025 2024 Membership and re$ear¢h Representation income Membership subscriptions 1,017 7,920 8,937 7,740 7.740 7,740 7,740 Annual conference Conference exhibition only Delegate registration 19,618 30.793 50,411 19,618 30,793 50.411 8,743 22,356 31,099 Online Education Leadership programme income 5,000 5,000 63.151 63,151 40,036 OF the income from charitable activtties in 2024 £40,036 related to unrestricted funds. Page 18
Lung Cancer Nury3ing UK known as LCNUK Notes to the FinanGial Statements for the Year Ended 31 January 2025 . continu8d Expenditure Membership and rèsèarch Annual conference Online Education Totsl 2025 Totsl 2024 Dire¢t Costs Grants payable - individuals Webinar costs Leadership programme expenditure Membership administration costs TSG committee costs Website costs Navigator group expenditure Dependency lotsl RIG ¢osts Annual workshop Online learning Venue costs Speaker costs and tokens Management fees conferen costs - materials Conference costs - other Irrecoverable VAT 1984) 1984} 5,846 4,455 12,533 1,061 4,328 570 10,113 4,000 5,846 4,455 12,533 1,061 4,328 570 11,699 1,148 4.545 225 110 1,171 6,789 110 54,804 2,025 11,500 16,709 14.806 {4771 139,277 1,936 8,333 2,708 1,936 8,333 2.708 43,664 3,444 11,500 20,088 19,437 43,664 11,500 20.068 19,437 31.469 97,129 10,301 138,899 Supportcosts Insuran off1management Committee costs Representation ¢osts Accountancy and bookkaeping fees Independent examinarts lee Bank charges 276 2,531 1.019 108 276 2,530 1,018 108 276 2,530 1,018 108 828 7,591 3,055 324 740 5.743 1,801 1.391 1,611 216 477 6,238 1.612 1,612 4.835 650 1,429 18,712 5.090 217 476 6,237 217 476 6,237 650 1,247 16,662 37,707 103,366 16,538 157,611 155,939 Of the total expenditure in 2024 £155,939 related to unrestricted funds. Page 19
Lung Cancer Nursing UK known as LCNUK Notss to the Financial Statements for the Year Ended 31 January 2025 . conlinued Grantmaklng Grants to individuals Annual conference 1984) Governance costs 2025 2024 Trustee meeting costs Accountsncy fees Bookeeping fees Independent examiners fee 677 1,685 3,150 650 6,162 410 1,905 3,150 650 6,115 Tru$ts•s' r•mun•ration and expenses Committee meeting and travel expenses totalling £387 (2024.. £3321 were paid to 4 {2024.- 11 of the trustees during the year. Page 20
Lung Cancer Nursing UK known as LCNUK Notes to the Financlal Statements forthe Year Endad 31 January 2025 . ntInued Taxation The registered charity is exempt from taxation on income and gains. 10 Debtors 2025 2024 Trade debtors Other deblors Prepayments and accTued income 47,858 7,453 50,948 58,401 374 48,232 11 Creditors: Amounts falling due within one wr 2025 2024 Trade creditorE Taxation and so¢ial security Other creditors Accruals and deferr6d income 1,787 116 6,919 340 27.687 29,814 50,700 57,735 Page21
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Endad 31 January 2025 . conlinued 12 Related parties Controlling entity The Charity is wntrolled by the trustees. 13 AnatyBis of fvnds At1 Fèbruary 2024 In¢oming resources Rosource8 At31 axpendod January 2025 General Funds Unrestricled income fvnd Prior ar 328,575 232,804 {157,611) 403,768 Atl February 2023 Incoming resources Resources At31 expendgd January 2024 General Funds UnrestriGed income fund 320,292 164.222 {155,939) 328,575 14 Nat agsets by fund Unrestricted Funds Total Funds 2025 Totsl Funds 2024 Current assets Creditors.. Amounts falling due within one year Net assets 433,582 129,8141 403,768 433,582 129,8141 403,768 386,310 {57,735) 328,575 Prior year Unrestrictgd funds Total fund8 2024 Total fundg 2023 Culrent assels Creditors.. Amounts falling due within one year Net asset5 386.310 157,7351 328,575 386,310 157.735) 328,575 332,710 {12,4181 320,292 Page 22